AI Insight
Researchers discovered that high blood sugar damages primary cilia, the microscopic sensory structures on cells in the eyes and kidneys, through a harmful feedback loop between two enzymes called PRMT1 and HDAC6. These enzymes become overactive under high glucose conditions and modify each other in ways that stabilize their interaction, leading to the breakdown of cilia and worsening diabetic complications in the retina and kidneys. When either enzyme was genetically removed or pharmacologically blocked in diabetic mice, ciliary structure was preserved and organ function improved.
Why it matters
This research identifies a specific molecular mechanism behind diabetic eye and kidney damage, offering concrete drug targets for preventing or treating diabetic retinopathy and nephropathy. Existing inhibitors of PRMT1 and HDAC6 could potentially be repurposed to protect patients with diabetes from these severe complications.
Understand the Science
by Jie Ran, Changfeng Wei, Yang Yang, Yufei Zhang, Guizhi Guo, Nan Ma, Long Yin, Hongjun Fan, Jingrui Li, Heng Guo, Renshuai Zhang, Runa Wang, Dengwen Li, Min Liu
Primary cilia are essential microtubule-based sensory organelles, and their dysfunction has been increasingly linked to metabolic stress. However, the underlying molecular mechanisms remain poorly understood. Herein, we reveal that ciliary defects in retinal photoreceptors and renal tubules exacerbate tissue damage during the progression of diabetic complications. Under hyperglycemic stress, protein arginine methyltransferase 1 (PRMT1) and histone deacetylase 6 (HDAC6) are significantly upregulated in both retinal and renal tissues. Genetic ablation of either enzyme effectively preserves ciliary architecture and restores organ function in diabetic mice. Mechanistically, PRMT1 localizes to the basal body, where it interacts with and methylates HDAC6 at arginine 16, consequently enhancing HDAC6 stability. In turn, HDAC6 mediates the deacetylation of PRMT1 at lysine 128, which elevates PRMT1 protein levels. This mutual modification crosstalk establishes a pathological positive feedback loop that stabilizes a pro-disassembly complex at the basal body, thereby potentiating ciliary impairment and expediting the progression of diabetic complications. Pharmacological inhibition of the PRMT1-HDAC6 loop significantly attenuates the pathological features of both diabetic retinopathy and nephropathy. Collectively, our findings uncover a reciprocal regulatory mechanism mediated by deacetylation and arginine methylation that drives cilium disassembly under hyperglycemic stress, providing promising therapeutic targets for the treatment of metabolic ciliopathies.